There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Geron Corporation (GERN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.01, or 0.30%, to $3.31. The Geron Corporation has recorded 191,977 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Geron Corporation Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Plus Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $227.8 Million.
As a NASDAQ listed company, GERN falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $3.30 and fluctuated between $3.3000 as its day high and $2.8300 as its day low. The current market capitalization of Geron Corporation is $1.25B. A total of 20.69 million shares were traded on the day, compared to an average of 7.40M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, GERN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 7 BUYs and 0 SELLs from insiders. Insiders purchased 295,773 shares during that period but sold 0.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for GERN in the last 3 months, the mean price target is $5.33 with high estimates of $7.00 and low estimates of $4.00. In terms of 52-week highs and lows, GERN has a high of $3.84 and a low of $0.99.
As of this writing, GERN has an earnings estimate of -$0.09 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.08 per share and a lower estimate of -$0.11. The company reported an EPS of -$0.09 in the last quarter, which was 10.00% higher than expectations of -$0.1.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 6 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GERN is Overweight with a score of 4.80. A total of 5 analysts rated the stock as Buy while 1 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.